PDL1 Gene Gain Predicts an Unfavorable Prognosis in HIV-Positive Primary Central Nervous System Lymphoma
- PMID: 40710189
- PMCID: PMC12294013
- DOI: 10.3390/curroncol32070378
PDL1 Gene Gain Predicts an Unfavorable Prognosis in HIV-Positive Primary Central Nervous System Lymphoma
Abstract
Primary central nervous system lymphoma (PCNSL) refers to non-Hodgkin lymphoma (NHL) originating in the brain, eyes, spinal cord, and cerebrospinal fluid without the presence of lymphoma outside of the central nervous system [...].
Keywords: HIV; PDL1; fluorescence in situ hybridization; immunohistochemistry; primary central nervous system lymphoma.
Conflict of interest statement
There are no conflicts of interest in the present manuscript, including financial, consultant, institutional, or other relationships that might lead to bias or a conflict.
Figures




Similar articles
-
Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis.Clin Lymphoma Myeloma Leuk. 2023 Oct;23(10):733-741. doi: 10.1016/j.clml.2023.06.008. Epub 2023 Jun 26. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37453867
-
The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.BMC Cancer. 2022 Feb 20;22(1):190. doi: 10.1186/s12885-022-09275-z. BMC Cancer. 2022. PMID: 35184749 Free PMC article.
-
Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL).Cochrane Database Syst Rev. 2012 Nov 14;11:CD009355. doi: 10.1002/14651858.CD009355.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152274
-
Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.Virchows Arch. 2020 Jun;476(6):891-902. doi: 10.1007/s00428-019-02695-6. Epub 2019 Dec 6. Virchows Arch. 2020. PMID: 31811434
-
Clinicopathological analysis of primary central nervous system lymphoma in patients with or without HIV infection.Ann Diagn Pathol. 2024 Dec;73:152383. doi: 10.1016/j.anndiagpath.2024.152383. Epub 2024 Oct 11. Ann Diagn Pathol. 2024. PMID: 39418717
References
-
- Xiao Q., Liu Y., Shu X., Li Y., Zhang X., Wang C., He S., Li J., Li T., Liu T., et al. Molecular mechanisms of viral oncogenesis in haematological malignancies: Perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling. Exp. Hematol. Oncol. 2025;14:69. doi: 10.1186/s40164-025-00655-2. - DOI - PMC - PubMed
-
- Hai L., Friedel D., Hinz F., Hoffmann D.C., Doubrovinskaia S., Rohdjess H., Weidenauer K., Denisova E., Scheffler G.T., Kessler T., et al. Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas. Neuro-Oncology. 2025;27:979–992. doi: 10.1093/neuonc/noae251. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials